GlassScriptPhysician profile
Steven L Swengel
NPI 1316023823
$6,840.91
in general payments reported to CMS, 2019-2025
14 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,531 · 2020: $798 · 2021: $346 · 2022: $178 · 2023: $344 · 2024: $514 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956 · Education: $32.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $956.23 |
| Education | $32.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $2,651.37 | 2019-2022 | |
| Apyx Medical Corporation | $1,208.03 | 2019 | |
| Galderma Laboratories, L.P. | $1,090.28 | 2019-2025 | Dysport |
| Abbvie INC. | $492.54 | 2023-2025 | Botox |
| Solta Medical, A Division of Bausch Health US, LLC | $470.08 | 2019-2020 | |
| Allergan, INC. | $366.42 | 2019-2022 | |
| Pfizer INC. | $193.38 | 2019-2023 | |
| Revance Therapeutics, INC. | $137.20 | 2024 | Daxxify |
| Janssen Biotech, INC. | $54.08 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $49.82 | 2019-2020 | |
| Dermira, INC. | $48.02 | 2019-2020 | |
| Biofrontera INC. | $38.98 | 2019 | |
| Lilly USA, LLC | $23.06 | 2020 | |
| Celgene Corporation | $17.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Swengel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.